A Complement Weekend
An International Patient's Conference on aHUS and C3 Glomerulopathy / MPGN is being organised on the 14th and 15th of September…
An International Patient's Conference on aHUS and C3 Glomerulopathy / MPGN is being organised on the 14th and 15th of September…
There is now 7 days to go before the Global aHUS Poll is closed to further responses. This year Global aHUS…
The aHUS endeavours series continue with an interview with Bill and Cheryl Biermann whose family was affected by aHUS at the…
The United States Thrombotic Microangiopathy (USTMA) Consortium was formed in 2014 as a collaborative initiative to organize research efforts in the…
Immunocompromisation is a hall mark of aHUS. For those who are predisposed to it and for those who have had it…
Global Action will be attending the Foundation’s Baltimore aHUS patients conference from the 28th to the 30th April. Here you will…
Over the past 10 years the movement of involvement of patients in the development of medicines, their regulation and use has…
Two updates on the Global aHUS Community Advisory Board. There is some information about the inaugural set of CAB / PHARMA…
As advocates for the rare disease atypical haemolytic uraemic syndrome (atypical HUS), there’s only one group of patients and caregivers whose…